Wogonin reversed hypoxia-induced multidrug resistance of human colon cancer cells via suppression of HIF-1α and glycolysis, by inhibiting the PI3K/Akt signaling pathway [48]. The gene discussed is HIF1A; the disease is malignant colon neoplasm.